tangeretin has been researched along with silybin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Augereau, JM; Billon, M; Gleye, J; Herbert, JM; Lale, A; Leconte, M | 1 |
| Feng, SL; Li, YZ; Liu, CX; Liu, L; Liu, ZQ; Xie, Y; Yuan, ZW; Zhou, H | 1 |
| Chen, SY; Pang, XC; Suguro, R; Xie, Y; Yuan, ZW; Zhu, YZ | 1 |
3 other study(ies) available for tangeretin and silybin
| Article | Year |
|---|---|
Ability of different flavonoids to inhibit the procoagulant activity of adherent human monocytes.
Topics: Amino Acid Sequence; Blood Coagulation; Cell Adhesion; Endotoxins; Flavonoids; Humans; In Vitro Techniques; Interleukin-1; Molecular Sequence Data; Monocytes | 1996 |
Role of tangeretin as a potential bioavailability enhancer for silybin: Pharmacokinetic and pharmacological studies.
Topics: Animals; ATP-Binding Cassette Transporters; Biological Availability; Caco-2 Cells; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Dogs; Flavones; Humans; Madin Darby Canine Kidney Cells; Male; Mice, Inbred C57BL; Rats, Sprague-Dawley; Silybin | 2018 |
Combinational applicaton of silybin and tangeretin attenuates the progression of non-alcoholic steatohepatitis (NASH) in mice via modulating lipid metabolism.
Topics: Animals; Flavones; Lipid Metabolism; Liver; Male; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Protective Agents; Silybin | 2020 |